Please login to the form below

Immuno-oncology: The market opportunity for PD-1/PD-L1s


Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies, immune checkpoint inhibitors are showing particular promise.Our latest infographic is a snapshot of the PD-1/PD-L1 market at this time.

http://www.researchpartnership.com/news/2016/08/infographic-immunno-oncology/

23rd November 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Webinar: Rich in potential - Exploring the opportunity for nutritionals in emerging markets
Thursday 22nd February 2018 15:00 GMT / 10:00 EST / 16:00 CET
Research Partnership
A researcher’s guide to Key Driver Analysis
Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business
Research Partnership
Research Partnership sends a cheque for $10,000 to Forever Angels
Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania
Research Partnership
Pharma Market Research Conference, 2018
We are delighted to be presenting and exhibiting at PMRC, 14-15 February in Newark, NJ.
Research Partnership
Out of the shadows: Mental health in the Asia Pacific region
In the first of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Asia
Research Partnership
Research Partnership has published a new patient Living with Atopic Dermatitis (US) report

Research Partnership